Voloridge Investment Management
KRRO icon

Voloridge Investment Management’s Korro Bio KRRO Stock Holding History

Voloridge Investment Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,529
Closed -$392K – 1552
2021
Q4 		$392K Sell
1,529
-1,783
-54% -$542K ﹤0.01% 1441
2021
Q3 		$1.17M Sell
3,312
-1,635
-33% -$644K 0.01% 1235
2021
Q2 		$2.46M Sell
4,947
-9,238
-65% -$4.51M 0.02% 918
2021
Q1 		$6.74M Buy
+14,185
New +$27.6M 0.05% 435

Other funds holding KRRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Voloridge Investment Management's KRRO Position: Q1 2022 in Review

Voloridge Investment Management sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 1,529 shares — an estimated $392K sold.

Voloridge Investment Management first reported a position in KRRO in Q1 2021 and held it in 4 quarters. The position peaked at $6.74M in Q1 2021. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Voloridge Investment Management reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 1,529 Korro Bio shares in Q1 2022, an estimated $392K.
  • Voloridge Investment Management first reported a position in Korro Bio in Q1 2021 and held it in 4 quarters.
  • Voloridge Investment Management's Korro Bio position peaked at $6.74M in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.